Aspirin was a brand once. So were escalator, thermos, trampoline, cellophane, and the zipper.

Each belonged to one company, until the company won so completely that courts declared the name public property. The prize for total market victory turned out to be confiscation of the trophy.

Trademark lawyers call it genericide, and it produces the strangest ad campaigns in history: corporations begging you to use their name less. Xerox spent decades and millions pleading “you cannot xerox a xerox – you photocopy on a Xerox-brand copier,” which is the legal department fighting the marketing department’s greatest triumph.

Google survived its own court challenge in 2017 on a technicality of perception: yes, everyone says “google it,” but they still know Google is a company. The verb had swallowed the noun, and the lawyers held the line at the skin.

Now listen to any office this year: “just ChatGPT it.” The same migration aspirin managed a century ago (except aspirin needed a world war and a treaty, and this took about eighteen months).

A company’s name entering the language is the most valuable thing that can happen to it – and the beginning of its dissolution as property.

The word outlives the ownership. Versailles confiscated two of Bayer’s trademarks: Aspirin and Heroin. One went on curing headaches for free. The other – well. They’d marketed it as a cough remedy for children.

Bayer never quite surrendered, mind you. Aspirin is still its trademark in some eighty countries – in Canada, the capital A is a legal requirement. Every collapse leaves a few loyal provinces.

Language is the one commons that expropriates upward: it takes from the most successful and gives to absolutely everybody, no vote required, no compensation paid.

Which reframes what these companies actually won. The product gets copied, the patent expires, the stock eventually does what stocks do. The verb is the only part that’s immortal – and immortality’s one condition is that it stops belonging to you.

Every empire ends as vocabulary.

Share

Subscribe now